Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Findings from University of Texas, Center for Biodefense and Emerging Infectious Diseases in life sciences reported
June 24th, 2009
Researchers detail in 'Antigenic protein modifications in Ehrlichia,' new data in life sciences. According to recent research published in the journal Parasite Immunology, "To develop effective vaccination strategies against Ehrlichia, we have previously reported developing an animal model of cross-protection in which C57BL/6 mice primed with E. muris were resistant to lethal infection with Ixodes ovatus ehrlichia (IOE). Polyclonal antibody produced in mice after priming with E. muris and later injected with IOE-detected antigenic proteins in E. muris and IOE cell lysates." "Cross-reaction of antigenic proteins was observed when we probed both the E. muris and...
Source: Vaccine Weekly (2009-06-24)
|
